Seeing Is Believing
Currently out of the existing stock ratings of Edward Woo, 170 are a BUY (92.9%), 6 are a SELL (3.28%), 7 are a HOLD (3.83%).
Analyst Edward Woo, currently employed at ASCENDIANT, carries an average stock price target met ratio of 55.46% that have a potential upside of 53.97% achieved within 230 days.
Edward Woo’s has documented 341 price targets and ratings displayed on 35 stocks. The coverage is on Healthcare, Communication Services, Consumer Cyclical, Energy, Technology sectors.
Most recent stock forecast was given on GRPN, Groupon at 17-Mar-2025.
Analyst best performing recommendations are on PAVM (PAVMED).
The best stock recommendation documented was for PAVM (PAVMED) at 9/6/2023. The price target of $7 was fulfilled within 1 day with a profit of $0.63 (9.89%) receiving and performance score of 98.9.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$8
3 years 29 days ago
(03-Mar-2022)
2/2 (100%)
$4.13 (106.72%)
51
Buy
$7
$5.98 (586.27%)
$8
3 years 9 months 22 days ago
(10-Jun-2021)
3/4 (75%)
$2.93 (71.99%)
182
Which stock is Edward Woo is most bullish on?
Which stock is Edward Woo is most reserved on?
What Year was the first public recommendation made by Edward Woo?